Utility of UV Signature Mutations in the Diagnostic Assessment of Metastatic Head and Neck Carcinomas of Unknown Primary

Overview

Journal Head Neck Pathol

Specialties Oncology
Pathology

Date 2024 Feb 23

PMID 38393464

Authors

Karina Colossi Furlan

Daryoush Saeed-Vafa

Tiffani M Mathew

James J Saller

Sana O Tabbara

Theresa A Boyle

Bruce M Wenig

Juan C Hernandez-Prera

Affiliations

Soon will be listed here.

Abstract

Background: Metastatic carcinoma of unknown primary origin to the head and neck lymph nodes (HNCUP) engenders unique diagnostic considerations. In many cases, the detection of a high-risk human papillomavirus (HR-HPV) unearths an occult oropharyngeal squamous cell carcinoma (SCC). In metastatic HR-HPV-independent carcinomas, other primary sites should be considered, including cutaneous malignancies that can mimic HR-HPV-associated SCC. In this context, ultraviolet (UV) signature mutations, defined as ≥ 60% C→T substitutions with ≥ 5% CC→TT substitutions at dipyrimidine sites, identified in tumors arising on sun exposed areas, are an attractive and underused tool in the setting of metastatic HNCUP.

Methods: A retrospective review of institutional records focused on cases of HR-HPV negative HNCUP was conducted. All cases were subjected to next generation sequencing analysis to assess UV signature mutations.

Results: We identified 14 HR-HPV negative metastatic HNCUP to either the cervical or parotid gland lymph nodes, of which, 11 (11/14, 79%) had UV signature mutations, including 4 (4/10, 40%) p16 positive cases. All UV signature mutation positive cases had at least one significant TP53 mutation and greater than 20 unique gene mutations.

Conclusion: The management of metastatic cutaneous carcinomas significantly differs from other HNCUP especially metastatic HR-HPV-associated SCC; therefore, the observation of a high percentage of C→T with CC →TT substitutions should be routinely incorporated in next generation sequencing reports of HNCUP. UV mutational signatures testing is a robust diagnostic tool that can be utilized in daily clinical practice.

References

. Comprehensive genomic characterization of head and neck squamous cell carcinomas. Nature. 2015; 517(7536):576-82. PMC: 4311405. DOI: 10.1038/nature14129. View

McDowell L, Young R, Johnston M, Tan T, Kleid S, Liu C . p16-positive lymph node metastases from cutaneous head and neck squamous cell carcinoma: No association with high-risk human papillomavirus or prognosis and implications for the workup of the unknown primary. Cancer. 2016; 122(8):1201-8. DOI: 10.1002/cncr.29901. View

Lewis Jr J, Beadle B, Bishop J, Chernock R, Colasacco C, Lacchetti C . Human Papillomavirus Testing in Head and Neck Carcinomas: Guideline From the College of American Pathologists. Arch Pathol Lab Med. 2017; 142(5):559-597. DOI: 10.5858/arpa.2017-0286-CP. View

Shalhout S, Emerick K, Kaufman H, Miller D . Immunotherapy for Non-melanoma Skin Cancer. Curr Oncol Rep. 2021; 23(11):125. PMC: 8395379. DOI: 10.1007/s11912-021-01120-z. View

Calabrese L, Jereczek-Fossa B, Jassem J, Rocca A, Bruschini R, Orecchia R . Diagnosis and management of neck metastases from an unknown primary. Acta Otorhinolaryngol Ital. 2005; 25(1):2-12. PMC: 2639847. View

Schwaederle M, Elkin S, Tomson B, Carter J, Kurzrock R . Squamousness: Next-generation sequencing reveals shared molecular features across squamous tumor types. Cell Cycle. 2015; 14(14):2355-61. PMC: 4613537. DOI: 10.1080/15384101.2015.1053669. View

Wong S, Waldeck K, Vergara I, Schroder J, Madore J, Wilmott J . UV-Associated Mutations Underlie the Etiology of MCV-Negative Merkel Cell Carcinomas. Cancer Res. 2015; 75(24):5228-34. DOI: 10.1158/0008-5472.CAN-15-1877. View

Chung C, Guthrie V, Masica D, Tokheim C, Kang H, Richmon J . Genomic alterations in head and neck squamous cell carcinoma determined by cancer gene-targeted sequencing. Ann Oncol. 2015; 26(6):1216-1223. PMC: 4516044. DOI: 10.1093/annonc/mdv109. View

Boyle T, Mondal A, Saeed-Vafa D, Ananth S, Ahluwalia P, Kothapalli R . Guideline-Adherent Clinical Validation of a Comprehensive 170-Gene DNA/RNA Panel for Determination of Small Variants, Copy Number Variations, Splice Variants, and Fusions on a Next-Generation Sequencing Platform in the CLIA Setting. Front Genet. 2021; 12:503830. PMC: 8172991. DOI: 10.3389/fgene.2021.503830. View

10.

Chan J, Yeh I, El-Sayed I, Algazi A, Glastonbury C, Ha P . Ultraviolet light-related DNA damage mutation signature distinguishes cutaneous from mucosal or other origin for head and neck squamous cell carcinoma of unknown primary site. Head Neck. 2019; 41(6):E82-E85. DOI: 10.1002/hed.25613. View

11.

Fishbach S, Steinhardt G, Zhen C, Puranik R, Segal J, Cipriani N . High Rates of Ultraviolet-Signature Mutations in Squamous Cell Carcinomas of the Parotid Gland and Prognostic Implications. Head Neck Pathol. 2021; 16(1):236-247. PMC: 9018939. DOI: 10.1007/s12105-021-01349-x. View

12.

Helleday T, Eshtad S, Nik-Zainal S . Mechanisms underlying mutational signatures in human cancers. Nat Rev Genet. 2014; 15(9):585-98. PMC: 6044419. DOI: 10.1038/nrg3729. View

13.

Colebatch A, Stefano L, Wong S, Hannan R, Waring P, Dobrovic A . Clustered somatic mutations are frequent in transcription factor binding motifs within proximal promoter regions in melanoma and other cutaneous malignancies. Oncotarget. 2016; 7(41):66569-66585. PMC: 5341821. DOI: 10.18632/oncotarget.11892. View

14.

Brash D . UV signature mutations. Photochem Photobiol. 2014; 91(1):15-26. PMC: 4294947. DOI: 10.1111/php.12377. View

15.

Lopez F, Rodrigo J, Silver C, Haigentz Jr M, Bishop J, Strojan P . Cervical lymph node metastases from remote primary tumor sites. Head Neck. 2015; 38 Suppl 1:E2374-85. PMC: 4991634. DOI: 10.1002/hed.24344. View

16.

Hartsough E, Mino-Kenudson M, Lennerz J, Dias-Santagata D, Hoang M . Clinical Next-Generation Sequencing Panels Reveal Molecular Differences Between Merkel Cell Polyomavirus-Negative Merkel Cell Carcinomas and Neuroendocrine Carcinomas. Am J Clin Pathol. 2023; 159(4):395-406. DOI: 10.1093/ajcp/aqac176. View

17.

Drobetsky E, Grosovsky A, Glickman B . The specificity of UV-induced mutations at an endogenous locus in mammalian cells. Proc Natl Acad Sci U S A. 1987; 84(24):9103-7. PMC: 299700. DOI: 10.1073/pnas.84.24.9103. View

18.

Saghatchian M, Fizazi K, Borel C, Ducreux M, Ruffie P, Le Chevalier T . Carcinoma of an unknown primary site: a chemotherapy strategy based on histological differentiation--results of a prospective study. Ann Oncol. 2001; 12(4):535-40. DOI: 10.1023/a:1011129429499. View

19.

Golusinski P, Di Maio P, Pehlivan B, Colley S, Nankivell P, Kong A . Evidence for the approach to the diagnostic evaluation of squamous cell carcinoma occult primary tumors of the head and neck. Oral Oncol. 2019; 88:145-152. DOI: 10.1016/j.oraloncology.2018.11.020. View

20.

Civantos F, Vermorken J, Shah J, Rinaldo A, Suarez C, Kowalski L . Metastatic Squamous Cell Carcinoma to the Cervical Lymph Nodes From an Unknown Primary Cancer: Management in the HPV Era. Front Oncol. 2020; 10:593164. PMC: 7685177. DOI: 10.3389/fonc.2020.593164. View